Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Comparison of cimetidine and placebo in the prevention of recurrence of ulceration was carried out in the study of 696 patients with recently healed duodenal ulcers. Treatment with cimetidine 400 mg at bedtime or twice daily for up to 12 months very significantly reduced recurrence of symptomatic ul...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1136/pgmj.56.653.173
データ提供:米国国立医学図書館(NLM)
Cimetidine: A Shield Against Ulcer Recurrence
The world of gastroenterology is a fascinating realm, where the delicate balance of stomach acid and mucosal protection plays a crucial role in our well-being. This research investigates the efficacy of cimetidine, a histamine H2 receptor antagonist, in preventing the recurrence of duodenal ulcers. The authors conducted an international collaborative study involving 696 patients with recently healed duodenal ulcers. They compared the effects of cimetidine treatment to placebo, with patients receiving either cimetidine 400 mg at bedtime or twice daily for up to 12 months.
Cimetidine: A Promising Shield
The results of this study indicate that cimetidine treatment significantly reduced the recurrence of symptomatic duodenal ulcers, both in the short term and long term. The authors observed a marked reduction in both symptomatic and asymptomatic ulcer recurrence in patients receiving cimetidine compared to those receiving placebo. This demonstrates the effectiveness of cimetidine in preventing duodenal ulcer recurrence.
A Beacon of Hope: Cimetidine for Ulcer Prevention
The study offers a beacon of hope for individuals struggling with recurrent duodenal ulcers. The findings suggest that cimetidine can be a valuable tool in preventing ulcer recurrence and improving overall gastrointestinal health. The research emphasizes the importance of personalized treatment plans and long-term management strategies to prevent ulcer recurrence.
Dr. Camel's Conclusion
This international collaborative study provides compelling evidence for the efficacy of cimetidine in preventing duodenal ulcer recurrence. The authors have diligently investigated the effects of cimetidine and have demonstrated its ability to significantly reduce the risk of ulcer recurrence. Their findings offer a valuable roadmap for improving the management of duodenal ulcers and promoting gastrointestinal well-being.
Date :
- Date Completed 1980-09-23
- Date Revised 2019-05-01
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.